Shares of Amrize Ltd (NYSE:AMRZ – Get Free Report) have received a consensus recommendation of “Hold” from the twenty brokerages that are currently covering the stock, MarketBeat Ratings reports. Five investment analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have given a buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $47.18.
AMRZ has been the subject of a number of analyst reports. Zacks Research lowered Amrize from a “hold” rating to a “strong sell” rating in a research report on Wednesday, August 19th. Royal Bank Of Canada lowered their price target on shares of Amrize from $48.00 to $32.00 and set an “underperform” rating for the company in a research report on Friday, October 9th. Oppenheimer cut their price objective on shares of Amrize from $55.00 to $52.00 and set an “outperform” rating on the stock in a research report on Monday, November 2nd. Longbow Research began coverage on shares of Amrize in a research note on Monday, October 12th. They set a “buy” rating for the company. Finally, Weiss Ratings cut shares of Amrize from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, October 8th.
Read Our Latest Analysis on Amrize
Insiders Place Their Bets
In other Amrize news, CEO Jan Jenisch purchased 26,000 shares of the stock in a transaction dated Wednesday, September 2nd. The shares were bought at an average cost of $42.47 per share, with a total value of $1,104,220.00. Following the completion of the acquisition, the chief executive officer owned 1,767,000 shares of the company’s stock, valued at approximately $75,044,490. This trade represents a 1.49% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jacques Sanche acquired 4,150 shares of the business’s stock in a transaction that occurred on Wednesday, August 26th. The shares were bought at an average price of $45.02 per share, for a total transaction of $186,833.00. Following the completion of the purchase, the director owned 9,766 shares of the company’s stock, valued at approximately $439,665.32. This represents a 73.90% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 34,155 shares of company stock valued at $1,461,276 in the last quarter. 0.54% of the stock is currently owned by insiders.
Institutional Trading of Amrize
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Pictet Asset Management Holding SA boosted its position in Amrize by 4.3% during the third quarter. Pictet Asset Management Holding SA now owns 6,126,150 shares of the company’s stock worth $230,110,000 after purchasing an additional 253,512 shares during the period. Allspring Global Investments Holdings LLC raised its position in shares of Amrize by 3.7% in the first quarter. Allspring Global Investments Holdings LLC now owns 4,772,941 shares of the company’s stock valued at $263,371,000 after purchasing an additional 171,622 shares during the period. Bank Julius Baer & Co. Ltd Zurich raised its position in shares of Amrize by 8.8% in the third quarter. Bank Julius Baer & Co. Ltd Zurich now owns 2,102,975 shares of the company’s stock valued at $78,985,000 after purchasing an additional 170,551 shares during the period. Renaissance Technologies LLC raised its position in shares of Amrize by 10.4% in the first quarter. Renaissance Technologies LLC now owns 1,956,600 shares of the company’s stock valued at $109,609,000 after purchasing an additional 183,900 shares during the period. Finally, Amundi lifted its stake in shares of Amrize by 30.9% in the first quarter. Amundi now owns 1,654,739 shares of the company’s stock worth $92,698,000 after buying an additional 390,750 shares during the last quarter.
Amrize Stock Performance
Shares of NYSE AMRZ opened at $39.84 on Wednesday. The company has a quick ratio of 0.67, a current ratio of 1.07 and a debt-to-equity ratio of 0.33. The firm’s 50-day moving average price is $39.22 and its two-hundred day moving average price is $49.85. Amrize has a 52-week low of $35.78 and a 52-week high of $65.94. The stock has a market capitalization of $22.03 billion, a P/E ratio of 18.03, a P/E/G ratio of 1.59 and a beta of 0.04.
Amrize (NYSE:AMRZ – Get Free Report) last posted its earnings results on Wednesday, October 28th. The company reported $1.05 EPS for the quarter, meeting the consensus estimate of $1.05. The company had revenue of $3.77 billion during the quarter. Amrize had a return on equity of 10.02% and a net margin of 9.93%. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period last year, the company posted $0.98 earnings per share. As a group, sell-side analysts forecast that Amrize will post 2.30 earnings per share for the current year.
Amrize Announces Dividend
The firm also recently announced a dividend, which will be paid on Wednesday, November 18th. Shareholders of record on Tuesday, November 10th will be paid a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, November 10th. Amrize’s payout ratio is presently 4.98%.
Amrize Company Profile
Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets. The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects. Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim’s North American business.
Further Reading
- Five stocks we like better than Amrize
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
